Abstract
Signal processing within DRGs The authors argue that parvalbumin-expressing primary sensory neurons (PV+ neurons) in the mouse dorsal root ganglion (DRG) gate the flow of noxious signals into the CNS in a manner analogous to that of the famous Gate Control theory of pain. The proposed mechanism is release of a neurotransmitter within the ganglion, rather than synaptic action in the dorsal horn. The released neurotransmitter excites nociceptors via a non-synaptic, apparently paracrine action. This is out-of-the-box thinking. Cell somata in the DRG are generally considered to be no more than metabolic factories tasked with maintaining their huge axons. They are not often thought of as significant contributors to sensory signal processing. The principal evidence given is that genetic ablation of most (~2/3) of the PV+ neurons in the L4DRG increases discharge rates of the residual (~1/3) PV+ neurons, recorded optically in anesthetized animals using GCaMP. This includes ongoing discharge and responsiveness to a variety of mechanical, thermal and chemical stimuli applied to the hindpaw skin. It also renders the mice behaviourally hypersensitive to the corresponding stimuli in the awake state. The authors are noncommittal about how this intra-ganglionic excitation works. One idea, based on observations of Gamper's group (Du et al. 2017 {1}), is that baseline discharge causes DRG cells to release GABA in the ganglion, thus inhibiting spike activity generated ectopically and suppressing pain behaviour. Ablating 2/3 of the GABAergic PV+ neurons might reduce this background GABAegic inhibition, thus exciting the residual 1/3 of PV+ neurons by disinhibition. Another idea was co-release of (excitatory) glutamate, along with GABA, from the PV+ neurons. Several minor caveats should be mentioned. For example: 1) the PV+ neurons recorded from are referred to as "proprioceptors", afferents that monitor joint angle and muscle contraction. But their receptive fields, and the stimuli applied to generate the enhanced discharge, were cutaneous and nociceptive. 2) Changing the membrane potential of DRG somata alters discharge originating from within the DRG, as Du et al. and many others have shown. But the response to stimulation at the sensory ending should not be affected (e.g. Amir & Devor 2003 {2}). 3) Moreover, our group failed to see inhibitory effects of GABA on ectopic discharge originating in DRG neurons (Koplovitch et al. 2018 {3}). 4) Partial nerve injury, the key manipulation used here, is an aspect of many rodent neuropathic pain models. A good deal of evidence based on these models suggests that the mechanism of hypersensitivity is primarily spinal, the same sort of modulation incorporated in the Gate Control theory, and not an exotic intra-ganglionic process. Be that as it may, intra-ganglionic signal processing is a good idea. Despite the fact that DRG afferents are among the most closely studied of all neurons in the nervous system, they exhibit a variety of peculiarities which remain mysterious to this day (Devor 1999 {4}). These include expression of numerous membranal synaptic receptors by DRG cell somata, and the release of neurotransmitters, despite the fact that virtually no synapses occur in DRGs. The suggestion that DRGs process and modify sensory signals, perhaps employing paracrine signalling, is intriguing and deserves continued research investment.